Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 9 EP applications Thomas Jürgen Lehmeier has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11716890

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Henkel Breuer & Partner
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13721353

CRYSTALLIZATION METHODS FOR PURIFICATION OF MONOCLONAL ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/16
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP13753180

METHODS FOR PURIFICATION OF ANTIBODIES USING ALIPHATIC ALCOHOLS

IPC classification:
C07K 1/30, C07K 16/06
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
The patent has been granted
EP13792030

OPTIMIZED EXPRESSION CASSETTE FOR EXPRESSING A POLYPEPTIDE WITH HIGH YIELD

IPC classification:
C12N 5/10, C12N 15/85
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
PATENT GRANTED
EP14714386

METHOD OF SCREENING CELL CLONES

IPC classification:
C12N 15/10, G01N 33/569
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP14753158

NOVEL SELECTION VECTORS AND METHODS OF SELECTING EUKARYOTIC HOST CELLS

IPC classification:
C07K 14/705, C12N 15/65, C12N 15/69, C12N 15/85
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11717240

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Markus Breuer, Henkel Breuer & Partner
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
PATENT GRANTED
EP14821860

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

IPC classification:
C07K 16/00
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14821859

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

IPC classification:
C07K 16/00, C12N 5/00
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature